Wide variations in the types of pain and response to analgesic pharmacotherapy mean that a variety of treatment strategies are needed. One approach is mesotherapy (intradermal therapy). This consists of microinjections into the skin and is ideally suited to the management of localized pain. Advantages include increasing the duration of drug activity, reduced risk of adverse events and interactions, and possible synergy with other therapies. Mesotherapy provides general practitioners with another tool for the treatment of local pain. However, it is important to provide patients with full details of the pros and cons of this approach and obtain informed patient consent.
There is heterogeneity between different types of pain due to different pathophysiological mechanisms and response to analgesics [1, 2] .
General practitioners (GPs) often detect persistent localized pain in patients with several coexisting disorders and who are at high risk of adverse events. In these circumstances, or when the use of pain medication is contraindicated or cannot be prescribed for long periods due to safety reasons, the GP needs alternative therapeutic strategies to control pain.
Mesotherapy (intradermal therapy) can be included as an additional treatment approach for the management of localized pain. It consists of a series of micro-injections in the upper layers of the skin. This allows a slow diffusion of the drug compared with deep-administration [3] . The micro-injections are performed using a syringe with a 4-mm (27 has become an alternative to the intramuscular route and is also being used for the administration of vaccines due to a greater immune response having been obtained with a lower dose of antigen compared to the intramuscular administration [5] . To practice this technique the following are required: clinical and pharmacological skills; ability to select patients to be treated; and communication skills to obtain valid informed consent. [6] . Over the years, in many countries there has been a growing interest in mesotherapy, especially in the field of esthetic medicine, both to correct skin disorders and to prevent the aging of the skin. The strong appeal of cosmetic applications for mesotherapy has resulted in use by non-medical personnel with a variety of off-label medications. Lack of compliance with minimum aseptic requirements during cosmetic uses has contributed to some adverse outcomes [7, 8] . reasons, and in these cases, opioids are suggested. However, these drugs should be used carefully to prevent iatrogenic risk [15] . A multimodal approach to pain may help to reduce a drug's toxicity by lowering the total dose of any single drug used to target different pain mechanisms. Under this point of view, unmanageable localized pain could benefit from a localized treatment that takes advantage of the principles of mesotherapy and may contribute to the reduction of the systemic administration of medications.
CONCLUSION
In conclusion, GPs should consider local analgesic strategies whenever systemic treatment increases the risk of drug reactions or interactions. In this setting, mesotherapy may be a useful ally against unnecessary pain.
However, it should be underlined that any analgesic technique has strengths and weaknesses. Therefore, the patient should be involved in pain management and informed about potential risks and failures. For this reason, informed consent is both good clinical practice and helps the patient to fully understand the limits and benefits of the therapeutic strategy proposed [6] . 
